January 28, 2010 2:47 PM
- Text
Sandoz Overcharged Medicaid by 60,000% in $13B Pricing Scam, Says Judge
(MoneyWatch) Novartis (NVS)' generics unit Sandoz overcharged Medicaid by 59,936 percent, according to a federal court ruling. That's not a typo: The alleged fraudulent overcharge was nearly sixty-thousand percent more than it should have been, according to complicated federal regulations that govern drug price reimbursement. (That means if Sandoz charged $1 for a pill, it told the government it cost $600.)
Novartis/Sandoz wasn't the only drug company draining the taxpayer's dime: Wyeth (now part of Pfizer (PFE)) overcharged by 17,421 percent and Mylan (MYL) overcharged by 33,641 percent, the ruling says. That overbilling came at a price, Judge Patti Saris (pictured) wrote:
Novartis/Sandoz wasn't the only drug company draining the taxpayer's dime: Wyeth (now part of Pfizer (PFE)) overcharged by 17,421 percent and Mylan (MYL) overcharged by 33,641 percent, the ruling says. That overbilling came at a price, Judge Patti Saris (pictured) wrote:
Collectively, the New York Medicaid program paid in excess of $13 billion between 1997 and 2003 for the prescription drugs at issue in these lawsuits.The case revolves around the "average wholesale price" at which the government reimburses doctors who prescribe drugs to patients. Companies are supposed to report the AWP to the government, which then reimburses the doctors at that price. However, in several rulings Saris has found that companies were inflating the AWP or reducing their actual prices, allowing doctors to keep the difference when Medicaid reimbursed them. In legal terms, that's an illegal kickback which ends up being paid for by the government. Saris ruled:
... actual acquisition costs as consistently above 50%, frequently over 100%, and sometimes over 1000%.Here's the list of offenders and the amounts by which they overcharged the government:
- Barr: 1,841%
- Dey: 3,998%
- Mylan: 33,641%
- Ivax: 1,893%
- Par: 13,486%
- Purepac: 1,103%
- Roxane: 206%
- Sandoz: 59,936%
- Schering-Warrick: 1,224%
- Teva: 2,955%
- Watson: 5,775%
- Wyeth: 17,421%
- Albuterol .90 mcg inhaler
- Albuterol .83 mg solution
- Cefadroxil 500 mg capsule
- Clonazepam .5 mg tablet
- Enalapril Maleate 20 mg tablet
- Isosorbide Mononitrate 60 mg tablet
- Lorazepam 1 mg tablet
- Metropolol 100 mg tablet
- Ranitidine 150 mg tablet
Latest Now in MoneyWatch
- Nationwide foreclosure pact gains momentum
- Board shake-up at Yahoo
- Fed: Consumer borrowing sees strong growth
- Greek debt talks drag on, banks signal progress
- Dow approaches 13,000, one rally from a record
- Market braces for federal budget battle
- How to handle passive aggressive employees | Leila's House of Corrections
- 4 ways to overcome price resistance on sales
- New York, Calif. holding out foreclosure settlement
- Bernanke sticks with low-rate policy at hearing
- Job openings up: Here's how to get one yourself
- Apple patent throws wrench into Facebook plans
- Yum! Brands forecasts strong expansion overseas
- Cash balance retirement plans: Annuity options
- Tax prep tips: Jill Schlesinger makes it easy
- Why is Greece negotiating over debt when it could be dictating?
- Job openings jump to a near 3-year high
Latest CBS News Headlines
on Facebook Most Discussed Stories
on CBS News
- Oil rises to near $99 after US crude supply drop
- Asia stocks up following surge on Wall Street
- Asia stocks up following surge on Wall Street
- Pa. House nears vote on gas drilling fee bill
on Facebook Most Discussed Stories
on CBS News






